Home
About the Journal
About
Editorial Board
Publication Ethics
Copyright
For Authors
Submissions
Guidelines for Authors
Article Processing Charge (APC)
Benefits for Authors
Copyright & Licensing
Current Issue
Archives
Italian edition
en
Announcements
Contacts
Register
Login
Home
About the Journal
About
Editorial Board
Publication Ethics
Copyright
For Authors
Submissions
Guidelines for Authors
Article Processing Charge (APC)
Benefits for Authors
Copyright & Licensing
Current Issue
Archives
Italian edition
Language
en
Search
Announcements
Contacts
Register
Login
Early responders within seven days of dupilumab treatment for severe asthma evaluated by patient-reported outcome: a pilot study
Make a Submission
FOR AUTHORS
SUBMIT YOUR PAPER
Article Processing Charge
Guide for Authors
Benefits for Authors
FOR REVIEWERS
Benefits for Reviewers
Thanks to Reviewers
INDEXING
PubMed
PubMed Central (PMC)
Scopus
DOAJ
ESCI
Embase
Academic Search
EBSCO
Google Scholar
OCLC
SCImago
Summon
COMMUNICATION
